Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City

Last updated: January 5, 2026
Sponsor: University of Missouri, Kansas City
Overall Status: Completed

Phase

N/A

Condition

Diabetes Mellitus Types I And Ii

Diabetes And Hypertension

Diabetes Prevention

Treatment

Behavioral Intervention with financial rewards and coaching

Control

Clinical Study ID

NCT06374186
2095072
2095072
  • Ages 18-65
  • All Genders

Study Summary

This study is evaluating a behavioral treatment program that uses diabetes coaching and financial rewards in addition to continuous glucose monitoring to improve diabetes management in adult patients with type 2 diabetes. This study will evaluate if this behavioral treatment program increases individual adherence to a diabetes treatment plan and improves blood sugar management.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Diagnosed with type 2 diabetes

  2. Age 18 to 65

  3. Hemoglobin A1c (blood draw or point-of-care) test available within the last 3 months

  4. Most recent hemoglobin A1c result between 8.0 and 11.0

  5. Currently receiving treatment for diabetes by a licensed healthcare provider.

  6. Reliable access to a personal smart phone that is compatible with CGM

  7. English speaking

Exclusion

Exclusion Criteria:

  1. Type 1 diabetes

  2. Secondary type 2 diabetes (diagnosis secondary to other medical conditions such aspancreatitis, Cystic Fibrosis, or Cushing disease)

  3. Prescribed short-acting (mealtime) insulin as part of diabetes treatment plan

  4. Known or acknowledged active substance use disorder or that would interfere ornegatively impact participation in the study

  5. Diagnosis of a medical/psychiatric condition that would prevent participation in thestudy (e.g., Intellectual Disability, Alzheimer's disease, Traumatic Brain Injury,Schizophrenia)

Study Design

Total Participants: 26
Treatment Group(s): 2
Primary Treatment: Behavioral Intervention with financial rewards and coaching
Phase:
Study Start date:
May 01, 2024
Estimated Completion Date:
August 12, 2025

Study Description

A randomized parallel-group pilot study of a combination intervention using Motivational Interviewing (MI) and Contingency Management (CM) for patients with T2DM. Individuals will be randomized in a 1:1 ratio to the intervention group or the control group. Randomization will be blocked and stratified by long-acting insulin and GLP1 medication use. All participants will be given a Continuous Glucose Monitor (CGM) to assess real-time blood sugar levels and establish CM rewards for those assigned to the treatment group.

Connect with a study center

  • University of Missouri - Kansas City School of Medicine

    Kansas City, Missouri 64108
    United States

    Site Not Available

  • University of Missouri - Kansas City School of Medicine

    Kansas City 4393217, Missouri 4398678 64108
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.